|
English
|
正體中文
|
简体中文
|
总笔数 :0
|
|
造访人次 :
52942248
在线人数 :
694
教育部委托研究计画 计画执行:国立台湾大学图书馆
|
|
|
"hsu c c"的相关文件
显示项目 21-30 / 1114 (共112页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
| 國立成功大學 |
2023 |
Adapting Object Detection to Fisheye Cameras: A Knowledge Distillation with Semi-Pseudo-Label Approach
|
Hsu, C.-C.;Tseng, W.-H.;Wu, M.-H.;Huang, W.-H.;Lee, C.-M. |
| 國立成功大學 |
2023 |
Swift Concurrent Semantic Segmentation and Object Detection on Edge Devices
|
Hsu, C.-C.;Jiang, Y.-Z.;Huang, W.-H. |
| 臺大學術典藏 |
2022-09-20T06:48:20Z |
Barriers to depression care among middle-aged and older adults in Taiwan's universal healthcare system
|
Chang T.-Y.; Liao S.-C.; Chang C.-M.; Wu C.-S.; Huang W.-L.; HWANG, JUEY-JEN; Hsu C.-C. |
| 臺大學術典藏 |
2022-09-19T03:16:29Z |
Sarcojoint?, the branched-chain amino acid-based supplement, plus resistance exercise improved muscle mass in adults aged 50 years and older: A double-blinded randomized controlled trial
|
Peng L.-N.; Yu P.-C.; Hsu C.-C.; Tseng S.-H.; Lee W.-J.; Lin M.-H.; FEI-YUAN HSIAO; Chen L.-K. |
| 臺大學術典藏 |
2022-09-19T03:16:28Z |
Muscle-to-fat ratio identifies functional impairments and cardiometabolic risk and predicts outcomes: biomarkers of sarcopenic obesity
|
Yu P.-C.; Hsu C.-C.; Lee W.-J.; Liang C.-K.; Chou M.-Y.; Lin M.-H.; FEI-YUAN HSIAO; Peng L.-N.; Chen L.-K. |
| 臺大學術典藏 |
2022-09-16T02:06:07Z |
White matter pathology in alzheimer’s transgenic mice with chronic exposure to low-level ambient fine particulate matter
|
Chen T.-F.; Lee S.-H.; Zheng W.-R.; Hsu C.-C.; Cho K.-H.; Kuo L.-W.; Chou C.C.-K.; MING-JANG CHIU; Tee B.L.; Cheng T.-J. |
| 臺大學術典藏 |
2022-09-15T03:32:28Z |
Trends in the incidence and prevalence of end-stage kidney disease requiring dialysis in Taiwan: 2010–2018
|
Lai T.-S.; Hsu C.-C.; Lin M.-H.; VIN-CENT WU; Chen Y.-M. |
| 臺大學術典藏 |
2022-09-15T03:00:15Z |
Trends in the incidence and prevalence of end-stage kidney disease requiring dialysis in Taiwan: 2010–2018
|
Lai T.-S.; Hsu C.-C.; Lin M.-H.; Wu V.-C.; YUNG-MING CHEN |
| 臺大學術典藏 |
2022-09-15T01:09:03Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Chia-Chi Lin; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-09-15T01:08:54Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Chia-Chi Lin; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
显示项目 21-30 / 1114 (共112页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
|
